We are live on ! Find out more
GCTK icon

GlucoTrack

7 hedge funds and large institutions have $273K invested in GlucoTrack in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital invested

Capital invested by funds: $163K → $273K (+$110K)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

13% less funds holding

Funds holding: 87 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
1
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change

GCTK Hedge Fund Activity: Q1 2024 in Review

7 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in GlucoTrack (GCTK) for Q1 2024, worth a combined $273K — up 68% from $163K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of GCTK and 3 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was Sabby Management, adding an estimated $48.6K. The largest seller was Boston Financial Management, exiting entirely with an estimated $6.9K sold.

  • 7 institutional investors held GlucoTrack (GCTK) as of Q1 2024, down from 8 in Q4 2023.
  • Funds reported $273K of GlucoTrack stock for Q1 2024, up 68% quarter-over-quarter.
  • 3 funds opened new GlucoTrack positions in Q1 2024 and 4 closed out, a net change of -1 holder.
  • The largest GlucoTrack buyer in Q1 2024 was Sabby Management, an estimated $48.6K added.
  • The largest GlucoTrack seller in Q1 2024 was Boston Financial Management, an estimated $6.9K sold.

Based on aggregated 13F filings for Q1 2024.